期刊信息查詢系統

期刊標題檢索 CURR DRUG METAB 最新評論: I submitted my paper in October 2023, and it's now February 2024. I... (2024-02-07)

[CURRENT DRUG METABOLISM]您好，您是該頁面的第 30723 位訪客。

期刊簡介

期刊名稱

CURRENT DRUG METABOLISM
LetPub Score

6.2

50 ratings

Rate

Reputation

7.4

Influence

5.1

Speed

6.8

期刊簡稱

CURR DRUG METAB

ISSN

1389-2002

E-ISSN

1875-5453

h-index

CiteScore

SJR

SNIP

CiteScore Rank

3.90

0.492

0.494

Subject field	Quartiles	Rank	Percentile
Category: Biochemistry, Genetics and Molecular Biology Subcategory: Clinical Biochemistry	Q3	69 / 124
Category: Biochemistry, Genetics and Molecular Biology Subcategory: Pharmacology	Q3	184 / 328

自引率 (2023-2024)

4.80%自引率趨勢

掲載範囲

Current Drug Metabolism aims to cover all the latest and outstanding developments in drug metabolism, pharmacokinetics, and drug disposition. The journal serves as an international forum for the publication of full-length/mini review, research articles and guest edited issues in drug metabolism. Current Drug Metabolism is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the most important developments. The journal covers the following general topic areas: pharmaceutics, pharmacokinetics, toxicology, and most importantly drug metabolism.

More specifically, in vitro and in vivo drug metabolism of phase I and phase II enzymes or metabolic pathways; drug-drug interactions and enzyme kinetics; pharmacokinetics, pharmacokinetic-pharmacodynamic modeling, and toxicokinetics; interspecies differences in metabolism or pharmacokinetics, species scaling and extrapolations; drug transporters; target organ toxicity and interindividual variability in drug exposure-response; extrahepatic metabolism; bioactivation, reactive metabolites, and developments for the identification of drug metabolites. Preclinical and clinical reviews describing the drug metabolism and pharmacokinetics of marketed drugs or drug classes.

官方網站

http://benthamscience.com/journal/index.php?journalID=cdm

在線稿件提交

http://bsp-cms.eurekaselect.com/index.php/CDM

開放訪問

出版商

Bentham Science Publishers B.V.

主題領域

医学

出版國/地區

NETHERLANDS

發行頻率

四半期刊行

創刊年

2000

每年文章數

56每年文章數趨勢

黃金OA百分比

6.04%

Web of Science 四分位
（ 2023-2024）

WOS Quartile: Q3

Category	Edition	JIF Quartile	JIF Ranking	JIF Percentage
BIOCHEMISTRY & MOLECULAR BIOLOGY	SCIE	Q4	253/328
PHARMACOLOGY & PHARMACY	SCIE	Q3	226/356

索引 (SCI or SCIE)

Science Citation Index Expanded

鏈接到PubMed Central (PMC)

https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1389-2002%5BISSN%5D

平均審稿時間 *

來自出版商的數據:
來自作者的數據: Sort of slow, 4-8 Week(s)

競爭力 *

來自作者的數據: Ordinary

參考鏈接

相關期刊	【CURRENT DRUG METABOLISM】CiteScore趨勢
自引率趨勢	每年文章數趨勢
作者評論

*所有的審稿過程指標，如接受率和審稿速度，僅限於用戶提交的稿件。因此，這些指標可能無法準確反映期刊的競爭力或速度。

同一學科的期刊
CiteScore趨勢
自引率趨勢
每年文章數趨勢

學科內的可信期刊	影響因子
NATURE MEDICINE	H-index: 497 CiteScore: 73.90
CELL	H-index: 705 CiteScore: 67.80
Molecular Cancer	H-index: 103 CiteScore: 55.00
Molecular Plant	H-index: 85 CiteScore: 39.20
NUCLEIC ACIDS RESEARCH	H-index: 452 CiteScore: 29.80
Molecular Cell	H-index: 356 CiteScore: 27.00
PROGRESS IN LIPID RESEARCH	H-index: 132 CiteScore: 34.60
TRENDS IN MICROBIOLOGY	H-index: 172 CiteScore: 25.90
CELL DEATH AND DIFFERENTIATION	H-index: 193 CiteScore: 29.30
Nature Chemical Biology	H-index: 182 CiteScore: 22.80

學科內最受檢索的期刊	頁面查看次數
International Journal of Biological Macromolecules	2068683
CELL BIOCHEMISTRY AND BIOPHYSICS	1221345
FASEB JOURNAL	799934
NUCLEIC ACIDS RESEARCH	733006
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS	724114
Molecular Cancer	416057
JOURNAL OF BIOLOGICAL CHEMISTRY	405970
International Journal of Biological Sciences	348965
GENETICS AND MOLECULAR RESEARCH	348527
CELL	324452

明年預測:
穩步上升無變化逐步下降　刷新

首頁上一頁 1 下一頁末頁 (頁 /1)
[CURRENT DRUG METABOLISM] 的評論	撰寫評論

作者: wangss0321 領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2024-02-07 08:51:54 評論於 I submitted my paper in October 2023, and it's now February 2024. I can't wait any longer, so I decided to withdraw it. It has been months of just going through the formal review process, with one small issue after another every month. I have to constantly prove my existence and that of other authors. I have spent months just trying to verify authors' CVs. This journal is really strict (0) 讚！ \| wangss0321
作者: Cathy757 領域: 医学審稿時間: 2.0 month(s) 結果: 修改後接受撰寫評論	2023-01-26 10:33:35 評論於 A relatively specialized journal in the field of drug metabolism, with a slow review process and a stagnant impact factor in recent years. I hope that the editor-in-chief of the journal can improve the level of quality control for articles and promote the development of drug metabolism research. (0) 讚！ \| Cathy757
作者: 宋振光博士領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2023-01-01 16:53:02 評論於 Submission for two months, no change in status. (0) 讚！ \| 宋振光博士
作者: 宋振光博士領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2022-12-03 14:42:41 評論於 No movement for a month since the submission. (0) 讚！ \| 宋振光博士
作者: 维尔娜菲茨杰拉德領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2021-12-30 20:42:35 評論於 The review process may be taking longer than expected, and it has not been completed yet (0) 讚！ \| 维尔娜菲茨杰拉德
作者: 维尔娜菲茨杰拉德領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2021-12-30 13:21:30 評論於 Submission completed -- Format review -- Editor initial review -- Peer review -- Review completed -- Editor final review -- Author revision (0) 讚！ \| 维尔娜菲茨杰拉德
作者: 上清雨真領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2021-12-28 22:54:35 評論於 What is the process of peer review? (0) 讚！ \| 上清雨真
作者: 修然小公主領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2021-12-26 10:53:00 評論於 Why haven't I heard back after a month of applying? (0) 讚！ \| 修然小公主
作者: 风陵幼双領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2017-10-09 20:39:44 評論於 This magazine is a joke. Four reviewers provided standard revision suggestions, but the editor rejected it without any reasons. The pace is extremely slow (0) 讚！ \| 风陵幼双
作者: 匿名領域: 審稿時間: 0.0 month(s) 結果: 撰寫評論	2012-09-15 13:33:00 評論於 The current impact factor is still high for this journal. However, I don’t understand this because this journal has been publishing lower quality articles in its recent issues. Some of the articles are equivalent to those published in JCB and JPBA… (0) 讚！ \| 匿名
作者: 凌霄高洁領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2011-06-29 19:41:50 評論於 Research Focus: Metabolism (0) 讚！ \| 凌霄高洁
作者: 谷翠小公主領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2011-06-28 14:43:33 評論於 Research Focus: Metabolism (0) 讚！ \| 谷翠小公主

首頁上一頁 1 下一頁末頁 (頁 /1)

開始撰寫 [CURRENT DRUG METABOLISM] 的評論：

您的評論將是選擇期刊的重要參考信息。歡迎分享您的投稿經驗！
研究領域:
接受狀態:	審稿時間: 個月以內
您的評論:
姓名:	(建議: 請輸入有效的電子郵件地址以便與審稿者互動，或註冊LetPub帳戶。)
給管理員留言:	我的評論包含修正信息如果您發現該期刊頁面中有錯誤的信息或希望提供額外內容，請勾選此框。管理員將檢查並儘快更新期刊說明。
隨機碼:	點擊刷新

期刊名稱:	ISSN:	主題領域:	影響因子範圍: -
索引:	類別:	開放訪問:	排序方式:

作者: wangss0321 領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2024-02-07 08:51:54 評論於 I submitted my paper in October 2023, and it's now February 2024. I can't wait any longer, so I decided to withdraw it. It has been months of just going through the formal review process, with one small issue after another every month. I have to constantly prove my existence and that of other authors. I have spent months just trying to verify authors' CVs. This journal is really strict (0) 讚！ \| wangss0321
作者: Cathy757 領域: 医学審稿時間: 2.0 month(s) 結果: 修改後接受撰寫評論	2023-01-26 10:33:35 評論於 A relatively specialized journal in the field of drug metabolism, with a slow review process and a stagnant impact factor in recent years. I hope that the editor-in-chief of the journal can improve the level of quality control for articles and promote the development of drug metabolism research. (0) 讚！ \| Cathy757
作者: 宋振光博士領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2023-01-01 16:53:02 評論於 Submission for two months, no change in status. (0) 讚！ \| 宋振光博士
作者: 宋振光博士領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2022-12-03 14:42:41 評論於 No movement for a month since the submission. (0) 讚！ \| 宋振光博士
作者: 维尔娜菲茨杰拉德領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2021-12-30 20:42:35 評論於 The review process may be taking longer than expected, and it has not been completed yet (0) 讚！ \| 维尔娜菲茨杰拉德
作者: 维尔娜菲茨杰拉德領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2021-12-30 13:21:30 評論於 Submission completed -- Format review -- Editor initial review -- Peer review -- Review completed -- Editor final review -- Author revision (0) 讚！ \| 维尔娜菲茨杰拉德
作者: 上清雨真領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2021-12-28 22:54:35 評論於 What is the process of peer review? (0) 讚！ \| 上清雨真
作者: 修然小公主領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2021-12-26 10:53:00 評論於 Why haven't I heard back after a month of applying? (0) 讚！ \| 修然小公主
作者: 风陵幼双領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2017-10-09 20:39:44 評論於 This magazine is a joke. Four reviewers provided standard revision suggestions, but the editor rejected it without any reasons. The pace is extremely slow (0) 讚！ \| 风陵幼双
作者: 匿名領域: 審稿時間: 0.0 month(s) 結果: 撰寫評論	2012-09-15 13:33:00 評論於 The current impact factor is still high for this journal. However, I don’t understand this because this journal has been publishing lower quality articles in its recent issues. Some of the articles are equivalent to those published in JCB and JPBA… (0) 讚！ \| 匿名
作者: 凌霄高洁領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2011-06-29 19:41:50 評論於 Research Focus: Metabolism (0) 讚！ \| 凌霄高洁
作者: 谷翠小公主領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2011-06-28 14:43:33 評論於 Research Focus: Metabolism (0) 讚！ \| 谷翠小公主

首頁上一頁 1 下一頁末頁 (頁 /1)

CURRENT DRUG METABOLISM

期刊標題檢索 CURR DRUG METAB 最新評論: I submitted my paper in October 2023, and it's now February 2024. I... (2024-02-07)

[CURRENT DRUG METABOLISM]您好，您是該頁面的第 30723 位訪客。

開始撰寫 [CURRENT DRUG METABOLISM] 的評論：

Contact us